M&A Deal Summary |
|
|---|---|
| Date | 2012-11-23 |
| Target | Centrovet Laboratories |
| Sector | Life Science |
| Buyer(s) | Virbac |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1968 |
| Sector | Life Science |
| Employees | 6,365 |
| Revenue | 1.4B EUR (2024) |
Virbac is a veterinary independent pharmaceutical company. Virbac was founded in 1968 and is based in Carros, France.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 6 |
| Sector: Life Science M&A | 2 of 4 |
| Type: Add-on Acquisition M&A Deals | 1 of 4 |
| Country: Chile M&A | 1 of 1 |
| Year: 2012 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-12 |
Pfizer - Veterinary Products
Australia Virbac will acquire rights to a portfolio of livestock products historically marketed in Australia by Fort Dodge Animal Health for use in farm animals, primarily cattle and sheep. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-27 |
Eli Lilly & Co. - Sentinel and Spectrum Brands
Indianapolis, Indiana, United States Virbac would acquire a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets, related to two major parasiticides for dogs: Sentinel® Flavor Tabs and Sentinel® Spectrum, currently marketed in the United States by Novartis Animal Health. |
Buy | $410M |
